144 related articles for article (PubMed ID: 36210729)
1. Inhibition of autophagy impairs free fatty acid-induced excessive lipid accumulation in hepatocellular carcinoma and hepatic cells.
Chen X; Liu H; Chen K; Guo Y; Mo T; Gao T
J Biosci; 2022; 47():. PubMed ID: 36210729
[TBL] [Abstract][Full Text] [Related]
2. [Huazhi Rougan Granules attenuates steatosis in cell model of nonalcoholic fatty liver disease by inducing autophagy].
Shi YM; Fu ZH; Zhu CS; Li XP
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1770-1778. PubMed ID: 37282951
[TBL] [Abstract][Full Text] [Related]
3. Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease.
Chavez-Tapia NC; Rosso N; Tiribelli C
BMC Gastroenterol; 2012 Mar; 12():20. PubMed ID: 22380754
[TBL] [Abstract][Full Text] [Related]
4. Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK/mTOR signaling pathway.
Yan LS; Zhang SF; Luo G; Cheng BC; Zhang C; Wang YW; Qiu XY; Zhou XH; Wang QG; Song XL; Pan SY; Zhang Y
Metabolism; 2022 Jun; 131():155200. PubMed ID: 35405150
[TBL] [Abstract][Full Text] [Related]
5. Liraglutide reduces lipid accumulation in steatotic L‑02 cells by enhancing autophagy.
Zhou SW; Zhang M; Zhu M
Mol Med Rep; 2014 Nov; 10(5):2351-7. PubMed ID: 25230688
[TBL] [Abstract][Full Text] [Related]
6. The ménage à trois of autophagy, lipid droplets and liver disease.
Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
[TBL] [Abstract][Full Text] [Related]
7. ω-3 Fatty acids reverse lipotoxity through induction of autophagy in nonalcoholic fatty liver disease.
Chen Y; Xu C; Yan T; Yu C; Li Y
Nutrition; 2015; 31(11-12):1423-1429.e2. PubMed ID: 26429665
[TBL] [Abstract][Full Text] [Related]
8. Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
Kurt R; Chandra PK; Aboulnasr F; Panigrahi R; Ferraris P; Aydin Y; Reiss K; Wu T; Balart LA; Dash S
PLoS One; 2015; 10(5):e0125962. PubMed ID: 25961570
[TBL] [Abstract][Full Text] [Related]
9. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model.
Im AR; Kim YH; Lee HW; Song KH
J Med Food; 2016 May; 19(5):495-503. PubMed ID: 27152979
[TBL] [Abstract][Full Text] [Related]
10. Magnesium Supplementation Stimulates Autophagy to Reduce Lipid Accumulation in Hepatocytes via the AMPK/mTOR Pathway.
Chen S; Luo S; Zou B; Xie J; Li J; Zeng Y
Biol Trace Elem Res; 2023 Jul; 201(7):3311-3322. PubMed ID: 36224316
[TBL] [Abstract][Full Text] [Related]
11. Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line.
Zhou D; Li BH; Wang J; Ding YN; Dong Y; Chen YW; Fan JG
PLoS One; 2016; 11(10):e0165224. PubMed ID: 27760195
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway.
Xue W; Wang J; Jiang W; Shi C; Wang X; Huang Y; Hu C
Eur J Pharmacol; 2020 Mar; 871():172910. PubMed ID: 31926991
[TBL] [Abstract][Full Text] [Related]
13. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Long JK; Dai W; Zheng YW; Zhao SP
Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
[TBL] [Abstract][Full Text] [Related]
14. Blueberry polyphenols play a preventive effect on alcoholic fatty liver disease C57BL/6 J mice by promoting autophagy to accelerate lipolysis to eliminate excessive TG accumulation in hepatocytes.
Zhuge Q; Zhang Y; Liu B; Wu M
Ann Palliat Med; 2020 May; 9(3):1045-1054. PubMed ID: 32389004
[TBL] [Abstract][Full Text] [Related]
15. Roles of Autophagy and Protein Kinase C-epsilon in Lipid Metabolism of Nonalcoholic Fatty Liver Cell Models.
Yan R; Niu CY; Tian Y
Arch Med Res; 2018 Aug; 49(6):381-390. PubMed ID: 30573200
[TBL] [Abstract][Full Text] [Related]
16. FMO1 Promotes Nonalcoholic Fatty Liver Disease Progression by Regulating PPARα Activation and Inducing Ferroptosis.
Zou L; Shi Q; Li Y; Yuan Z; Peng L; Lu J; Zhu H; Ma J
Discov Med; 2023 Aug; 35(177):612-622. PubMed ID: 37553313
[TBL] [Abstract][Full Text] [Related]
17. Cellular and molecular alterations in a human hepatocellular in vitro model of nonalcoholic fatty liver disease development and stratification.
Willett RA; Tryndyak VP; Beland FA; Pogribny IP
J Environ Sci Health C Toxicol Carcinog; 2024; 42(1):74-92. PubMed ID: 38105681
[TBL] [Abstract][Full Text] [Related]
18. Deranged hepatocyte intracellular Ca
Ali ES; Rychkov GY; Barritt GJ
Cell Calcium; 2019 Sep; 82():102057. PubMed ID: 31401389
[TBL] [Abstract][Full Text] [Related]
19. [Urolithin A inhibits inflammation and oxidative stress induced by high lipid in hepatocytes via activating Nrf2 pathway and autophagy].
Yin C; Wang Y; Peng Y; Zhang R; Sun N; Shi C; Liu Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Nov; 37(11):973-980. PubMed ID: 34809736
[TBL] [Abstract][Full Text] [Related]
20. Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice.
Tanaka S; Hikita H; Tatsumi T; Sakamori R; Nozaki Y; Sakane S; Shiode Y; Nakabori T; Saito Y; Hiramatsu N; Tabata K; Kawabata T; Hamasaki M; Eguchi H; Nagano H; Yoshimori T; Takehara T
Hepatology; 2016 Dec; 64(6):1994-2014. PubMed ID: 27637015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
